Regulation of chemokine receptor expression profiles in head and neck cancer

by Da-Liang Ou, 歐大諒
Published 2007

Mouse Models for Immunotherapy in Hepatocellular Carcinoma

by Enya Li, Li Lin, Chia-Wei Chen, Da-Liang Ou
Published 2019-11-01

Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway.

by Da-Liang Ou, Bin-Shyun Lee, Ya-Chi Chang, Liang-In Lin, Jun-Yang Liou, Chiun Hsu, Ann-Lii Cheng
Published 2013-01-01

Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations—Possible Therapeutic Efficacy of Cabozantinib

by Ya-Chen Ko, Chung-Yi Hu, Zheng-Hau Liu, Hwei-Fang Tien, Da-Liang Ou, Hsiung-Fei Chien, Liang-In Lin
Published 2019-03-01

TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

by Hui‐Huang Lai, Chih‐Wei Li, Chih‐Chen Hong, Hung‐Yu Sun, Ching‐Feng Chiu, Da‐Liang Ou, Pai‐Sheng Chen
Published 2019-04-01

Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma

by Chia-Lang Hsu, Da-Liang Ou, Li-Yuan Bai, Chia-Wei Chen, Li Lin, Shiu-Feng Huang, Ann-Lii Cheng, Yung-Ming Jeng, Chiun Hsu
Published 2021-05-01

KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells.

by Yu-Lin Lin, Jau-Yu Liau, Shan-Chi Yu, Da-Liang Ou, Liang-In Lin, Li-Hui Tseng, Yih-Leong Chang, Kun-Huei Yeh, Ann-Lii Cheng
Published 2012-01-01

Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages

by Ann-Lii Cheng, Da-Liang Ou, Chia-Wei Chen, Chia-Lang Hsu, Chih-Hung Chung, Zi-Rui Feng, Bin-Shyun Lee, Muh-Hwa Yang, Chiun Hsu
Published 2021-03-01